Research reports for the first time a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells.

Researchers have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers.

Researchers say they discovered that a special sugar molecule could play a key role in the development of Alzheimer’s disease.

Patients with Alzheimer’s disease (AD) have lower levels of the neuromodulator acetylcholine (ACh) in their brains.

A world-first study has confirmed the link between the two, which could lead to earlier detection and new potential treatments.

The prevention and removal of misfolded protein aggregates is considered a promising strategy to treat Alzheimer's Disease.

Drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity, and improves heart function.

An estimated 6.5 million Americans aged 65 and older are living with Alzheimer’s in 2022. That figure is predicted to nearly double by 2050.

Researchers have identified the intracellular signal cascade through which ACh regulates aversive learning, a major preliminary test for AD.

The molecule, known as a glycan, could serve as a new target for early diagnostic tests, treatments and perhaps prevention of Alzheimer’s.

Researchers discovered that increasing the production of new neurons in mice with Alzheimer’s disease rescues the animals’ memory defects.

The discovery of how to shift damaged brain cells from a diseased state into a healthy one presents a new path to treating Alzheimer's.

Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated protein

Scientists Identify the Molecular Mechanisms Behind Learning and Memory, May Open Door to New Therapeutic Strategies for Alzheimer’s Disease

The dementia disorder Alzheimer’s disease has a symptom-free course of 15 to 20 years before the first clinical symptoms emerge.

Researchers say they discovered that a special sugar molecule could play a key role in the development of Alzheimer’s disease.

Researchers have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity.

Mice fed a high-fat diet for 30 weeks were considerably more likely to develop diabetes, face cognitive impairments, and develop depression

Understanding the relationship between Alzheimer’s disease and the brain’s complex network of vessels and veins is a challenge for science.

People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease